OBJECTIVE： To provide reference for the further standardization of biological products injection for treatment instructions. METHODS： 32 biological products injection for treatment instructions collected from Ma’anshan Center for Disease Control and Prevention and Ma’anshan Central Hospital during Jan. to Jun. in 2015. The information of marked item was summarized and analyzed. RESULTS & CONCLUSIONS：  Among 32 biological products injection for treatment instructions，  the mark rates of drug names， main ingredients， character， indications， specification， usage and dosage， package， term of validity， operative norm， license number， manufacturing enterprise and other items all reached 100％. Although the mark rates of ADR， contraindication， precaution， drug use of pregnant women and nursing mothers， drug interactions， pharmacokinetics， drug use of the elderly， storage and other items were relatively high， but some items lacked the specific description of the content. The mark rates of drug use of children， drug overdose， toxicology， warnings， clinical trial were 56.25％， 62.50％， 59.38％， 37.50％ and 18.75％. Some biological products injection for treatment instructions are not revised timely and not complete in content and non-standard in writing， which can not meet the needs that clinical pharmacists and patients get enough drug safety information from instructions. Manufacturing enterprise is suggested to label the content of package inserts completely， verify and supplement related content， standardize and improve the instructions.